HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):: US40637H1095
LEI:
Country:: United States of America
Address:: 12390 EL CAMINO REAL, 92130 SAN DIEGO
Website:: https://www.halozyme.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
IntegraGen Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.	France	ALINT
INTENSITY THERAPEUTICS, INC. Develops injected therapies to kill tumors locally and activate a systemic immune response.	United States of America	INTS
InterDigital, Inc. Develops and licenses essential wireless, video, and AI technologies for mobile devices and networks.	United States of America	IDCC
Interworks Confidence Inc. Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.	Japan	7374
INTLOOP Inc. Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.	Japan	9556
IntoCell, Inc. Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.	South Korea	287840
Intracom S.A. Holdings A multinational group delivering IT solutions, defense electronics, and construction projects.	Greece	INTRK
Inventionmed Spolka Akcyjna Develops VR medical simulators with haptic feedback for dermatology training.	Poland	INM
Inventiva Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.	France	IVA
INVITES BIOCORE CO., LTD A CRO advancing precision medicine via genomic analysis and clinical trial support services.	South Korea	216400